Table 1. Preoperative clinical and multiparametric magnetic resonance imaging characteristics of patients undergoing radical prostatectomy.
| Clinical Characteristics | ||
| Median (IQR) | Total Cohort | Nomogram Cohort |
| Age, yr | 60 (55–65) | 58 (55–63) |
| BMI | 28 (26–31) | 28 (25–31) |
| Preoperative PSA, ng/ml | 5.5 (4.0–8.7) | 5.2 (3.7–9.9) |
| No (%) | ||
| Race | ||
| White | 240 (72.5) | 54 (64.3) |
| Black | 66 (19.9) | 19 (22.6) |
| Other | 25 (7.6) | 11 (13.1) |
| Clinical stage | ||
| T1c | 301 (90.9) | 71 (84.5) |
| ≥ T2a | 30 (9.1) | 13 (15.5) |
| Biopsy Gleason score | ||
| 6 | 90 (27.2) | 29 (34.5) |
| 7 | 184 (55.6) | 46 (54.8) |
| ≥ 8 | 57 (17.2) | 9 (10.7) |
| MP-MRI Characteristics | ||
| Median (IQR) | Total Cohort | Nomogram Cohort |
| MRI prostate volume, cc | 37 (30–47) | 39 (28–49) |
| MRI lesions, no | 2 (1–3) | 2 (1–3) |
| No (%) | ||
| MP—MRI suspicion score | ||
| Low | 45 (13.6) | 17 (20.2) |
| Moderate | 208 (62.8) | 37 (44.1) |
| High | 78 (23.6) | 30 (35.7) |
| mECE | ||
| Absent | 232 (70.0) | 56 (66.7) |
| Present | 99 (30.0) | 28 (33.3) |
| mSVI | ||
| Absent | 322 (97.3) | 83 (98.8) |
| Present | 9 (2.7) | 1 (1.2) |
BMI = body mass index, IQR = interquartile range, MRI = magnetic resonance imaging, MP-MRI = multiparametric magnetic resonance imaging, mECE = extracapsular extension on magnetic resonance imaging, mSVI = seminal vesicle invasion on magnetic resonance imaging, PSA = prostate-specific antigen.